Zengli Guo

Company: AstraZeneca

Job title: Associate Director, Cell Therapeutics

Seminars:

Unearthing Allogeneic Interactions to Understand their Function In Vivo 1:00 pm

Investigating the functional characteristics of allogenic Tregs to ascertain where they are most effective Discovering allogeneic mechanisms of action and immune system and target tissue interactions to identify key differences between the treatments Exploring criteria to ensure relevant therapy selection based upon varying disease types, severity and patient immune statusRead more

day: Day 1 Treg Cell Therapy Track